STK11 and cancer: To ask whether FBXO22 promotes cancer cell growth through LKB1/AMPK/mTOR pathway, we performed further analysis of downstream signaling pathways using p-AMPK(Thr172), p-Raptor(Ser792) and p-P70S6K(Thr389), as indicators of mTOR activation.